- CRSP +1.49%
CRISPR Therapeutics AG (CRSP) Outperforms Broader Market: What You Need to Know
Yahoo Finance · 15 hours ago
Open | 56.75 |
High | 58.45 |
Low | 55.57 |
Mkt Cap | 4.74B |
P/E (TTM) | N/A |
Div & Yield | N/A & N/A |
Prev. Close | 55.07 |
52 Wk. Low | 37.55 |
52 Wk. High | 91.10 |
Related stocks
Company in Basel, Switzerland
CRISPR Therapeutics AG is a Swiss–American biotechnology company headquartered in Zug, Switzerland. It was one of the first companies formed to utilize the CRISPR gene editing platform to develop medicines for the treatment of various rare and common diseases. Wikipedia
(USD) | Q4 2023 | Y/Y |
---|---|---|
Revenue | 201.21M | 3,353,333.20% ▲ |
Net Income | 89.35M | - |
Diluted EPS | 1.10 | - |
Quarter | EPS Estimate | EPS Actual |
---|---|---|
Q1 2024 | -$1.29 | - |
Q4 2023 | -$0.07 | $1.10 |
Q3 2023 | -$1.95 | -$1.41 |
S&P 500^GSPC | 5,127.79+63.59 (+1.26%) |
Dow 30^DJI | 38,675.68+450.02 (+1.18%) |
Nasdaq^IXIC | 16,156.33+315.37 (+1.99%) |
Bitcoin USDBTC-USD | 63,920.78+5.50% |
S&P 500^GSPC | 5,127.79+1.26% |
NASDAQ Composite^IXIC | 16,156.33+1.99% |